DML have received their unique identifier from the European Medicines Agency Organisation Management System, ORG-100045884

The European Commission has revised the rules for the conduct of clinical trials in the European Union (EU).  As a result, the European Clinical Trial Regulation (EU_CTR (Clinical Trial Regulation)) 536/2014 replaced the Clinical Trial Directive 2001/20/EC on 31-January-2022.  

The aim of the new regulation is to create an environment favourable to conducting trials in the EU, with the highest standards of safety for participants and increased transparency of trial information. 

As part of the new EU_CTR requirement, any vendor supporting clinical trials to be submitted in the EU are now required to register within the OMS database.    

The mission of the European Medicines Agency (EMA) is to foster scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health in the European Union (EU).

To find out more about the work of the EMA please click here.

We use cookies to provide best site experience. Cookie Policy